https://observatorio.fm.usp.br/handle/OPI/25684
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | CAVALCANTE, Isadora P. | - |
dc.contributor.author | NISHI, Mirian | - |
dc.contributor.author | ZERBINI, Maria Claudia N. | - |
dc.contributor.author | ALMEIDA, Madson Q. | - |
dc.contributor.author | BRONDANI, Vania B. | - |
dc.contributor.author | BOTELHO, Maria Luiza Anhaia de Arruda | - |
dc.contributor.author | TANNO, Fabio Y. | - |
dc.contributor.author | SROUGI, Victor | - |
dc.contributor.author | CHAMBO, Jose Luis | - |
dc.contributor.author | MENDONCA, Berenice B. | - |
dc.contributor.author | BERTHERAT, Jerome | - |
dc.contributor.author | LOTFI, Claudimara F. P. | - |
dc.contributor.author | FRAGOSO, Maria Candida B. V. | - |
dc.date.accessioned | 2018-03-06T15:19:42Z | - |
dc.date.available | 2018-03-06T15:19:42Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | MOLECULAR AND CELLULAR ENDOCRINOLOGY, v.460, n.C, p.36-46, 2018 | - |
dc.identifier.issn | 0303-7207 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/25684 | - |
dc.description.abstract | The participation of aberrant receptors and intra-adrenal ACTH in hyperplastic tissue are considered mechanisms that regulate hypercortisolism in PMAH. Additionally, germline ARMC5 mutations have been described as the most frequent genetic abnormality found in patients diagnosed with PMAH. Previous functional studies analyzed ARMC5 role using H295R cells. Therefore, we investigated the role of ARMC5 in cell cultures obtained from PMAH nodules containing steroidogenic cells, aberrant receptors and intra-adrenal ACTH. ARMC5 silencing in non-mutated PMAH cell cultures decreased steroidogenesis-related genes and increased CCNE1 mRNA expression and proliferative capacity without affecting cell viability. Additionally, ARMC5 overexpression induced cell death in PMAH mutated cell cultures, thereby decreasing cell viability. We confirmed the role of ARMC5 as an important pro-apoptotic protein involved in PMAH-related steroidogenesis. We also report for the first time the involvement of ARMC5 in controlling proliferation and regulating cell cycle in PMAH cell cultures; these effects need to be explored further. | - |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) | - |
dc.description.sponsorship | FAPESP [2015/50192-9] | - |
dc.description.sponsorship | CNPq [303092/2015-7] | - |
dc.language.iso | eng | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.relation.ispartof | Molecular and Cellular Endocrinology | - |
dc.rights | restrictedAccess | - |
dc.subject | Cushing syndrome | - |
dc.subject | PMAH | - |
dc.subject | Adrenocortical hyperplasia | - |
dc.subject | ARMC5 | - |
dc.subject | Cell cultures (5 words) | - |
dc.subject.other | adrenal cushings-syndrome | - |
dc.subject.other | protein-kinase-a | - |
dc.subject.other | acth | - |
dc.subject.other | expression | - |
dc.subject.other | mutations | - |
dc.subject.other | receptors | - |
dc.subject.other | corticotropin | - |
dc.subject.other | secretion | - |
dc.subject.other | growth | - |
dc.title | The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH) | - |
dc.type | article | - |
dc.rights.holder | Copyright ELSEVIER IRELAND LTD | - |
dc.identifier.doi | 10.1016/j.mce.2017.06.027 | - |
dc.identifier.pmid | 28676429 | - |
dc.subject.wos | Cell Biology | - |
dc.subject.wos | Endocrinology & Metabolism | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | CAVALCANTE, Isadora P.:Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil | - |
hcfmusp.author.external | BERTHERAT, Jerome:Univ Paris 05, Serv Endocrinol, Hop Cochin,Inst Cochin,CNRS 8104, Ctr Reference Malad Rares Surrenale,INSERM U 1016, Paris, France | - |
hcfmusp.author.external | LOTFI, Claudimara F. P.:Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil | - |
hcfmusp.description.beginpage | 36 | - |
hcfmusp.description.endpage | 46 | - |
hcfmusp.description.issue | C | - |
hcfmusp.description.volume | 460 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-85023634101 | - |
hcfmusp.origem.id | WOS:000423893300004 | - |
hcfmusp.publisher.city | CLARE | - |
hcfmusp.publisher.country | IRELAND | - |
hcfmusp.relation.reference | Alencar G.A., 2014, J CLIN ENDOCR METAB | - |
hcfmusp.relation.reference | Antonini Sonir R., 2004, Arq Bras Endocrinol Metab, V48, P620, DOI 10.1590/S0004-27302004000500006 | - |
hcfmusp.relation.reference | Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603 | - |
hcfmusp.relation.reference | Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615 | - |
hcfmusp.relation.reference | Bourdeau I, 2004, ENDOCR RES, V30, P575, DOI 10.1081/ERC-200043735 | - |
hcfmusp.relation.reference | Bourdeau I, 2002, ANN NY ACAD SCI, V968, P240, DOI 10.1111/j.1749-6632.2002.tb04339.x | - |
hcfmusp.relation.reference | Bourdeau I, 2016, EUR J ENDOCRINOL, V174, P85, DOI 10.1530/EJE-15-0642 | - |
hcfmusp.relation.reference | Boutillier A L, 1998, Pituitary, V1, P33, DOI 10.1023/A:1009966808106 | - |
hcfmusp.relation.reference | Correa R, 2015, EUR J ENDOCRINOL, V173, P435, DOI 10.1530/EJE-15-0205 | - |
hcfmusp.relation.reference | de Joussineau C, 2012, MOL CELL ENDOCRINOL, V351, P28, DOI 10.1016/j.mce.2011.10.006 | - |
hcfmusp.relation.reference | Drougat L, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00096 | - |
hcfmusp.relation.reference | Faucz F.R., 2014, J CLIN ENDOCR METAB | - |
hcfmusp.relation.reference | Fujii H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110543 | - |
hcfmusp.relation.reference | Gagliardi L, 2014, J CLIN ENDOCR METAB, V99, pE1784, DOI 10.1210/jc.2014-1265 | - |
hcfmusp.relation.reference | Hu Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13834 | - |
hcfmusp.relation.reference | Iwata M, 2012, INTERNAL MED, V51, P2181, DOI 10.2169/internalmedicine.51.7547 | - |
hcfmusp.relation.reference | KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1 | - |
hcfmusp.relation.reference | KIRSCHNER MA, 1964, J CLIN ENDOCR METAB, V24, P947, DOI 10.1210/jcem-24-10-947 | - |
hcfmusp.relation.reference | Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638 | - |
hcfmusp.relation.reference | Lacroix A, 2001, ENDOCR REV, V22, P75, DOI 10.1210/er.22.1.75 | - |
hcfmusp.relation.reference | Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004 | - |
hcfmusp.relation.reference | Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x | - |
hcfmusp.relation.reference | Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011 | - |
hcfmusp.relation.reference | LEBRETHON MC, 1994, MOL CELL ENDOCRINOL, V106, P137, DOI 10.1016/0303-7207(94)90195-3 | - |
hcfmusp.relation.reference | Lefebvre H, 2003, J CLIN ENDOCR METAB, V88, P3035, DOI 10.1210/jc.2002-030014 | - |
hcfmusp.relation.reference | Lefebvre H, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00098 | - |
hcfmusp.relation.reference | Lefebvre H, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00034 | - |
hcfmusp.relation.reference | Lodish M, 2016, NAT REV ENDOCRINOL, V12, P255, DOI 10.1038/nrendo.2016.24 | - |
hcfmusp.relation.reference | Louiset E, 2006, J CLIN ENDOCR METAB, V91, P4578, DOI 10.1210/jc.2006-0538 | - |
hcfmusp.relation.reference | Louiset E, 2013, NEW ENGL J MED, V369, P2115, DOI 10.1056/NEJMoa1215245 | - |
hcfmusp.relation.reference | Mattos GE, 2011, CELL TISSUE RES, V345, P343, DOI 10.1007/s00441-011-1220-8 | - |
hcfmusp.relation.reference | Mazzuco TL, 2007, ARQ BRAS ENDOCRINOL, V51, P1452, DOI 10.1590/S0004-27302007000900007 | - |
hcfmusp.relation.reference | Morioka M, 1997, ENDOCR J, V44, P65, DOI 10.1507/endocrj.44.65 | - |
hcfmusp.relation.reference | REDDY GPV, 1994, J CELL BIOCHEM, V54, P379, DOI 10.1002/jcb.240540404 | - |
hcfmusp.relation.reference | SASANO H, 1994, MODERN PATHOL, V7, P215 | - |
hcfmusp.relation.reference | Srougi V, 2016, UROLOGY, V90, P217, DOI 10.1016/j.urology.2015.11.043 | - |
hcfmusp.relation.reference | Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003 | - |
hcfmusp.relation.reference | Xing YW, 2010, J MOL ENDOCRINOL, V45, P59, DOI 10.1677/JME-10-0006 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 37 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - FM/MPT Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/14 Artigos e Materiais de Revistas Científicas - LIM/42 Artigos e Materiais de Revistas Científicas - ODS/03 |
File | Description | Size | Format | |
---|---|---|---|---|
art_CAVALCANTE_The_role_of_ARMC5_in_human_cell_cultures_2018.PDF Restricted Access | publishedVersion (English) | 2.3 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.